262 related articles for article (PubMed ID: 28317805)
1. Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria.
Mohammad AB; Iliyasu G; Habib AG
Int J Mycobacteriol; 2017; 6(1):47-51. PubMed ID: 28317805
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria.
Kehinde AO; Adebiyi EO
Niger J Physiol Sci; 2013 Dec; 28(2):187-91. PubMed ID: 24937395
[TBL] [Abstract][Full Text] [Related]
4. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
[TBL] [Abstract][Full Text] [Related]
5. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
Al-Mutairi NM; Ahmad S; Mokaddas E
Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.
Miotto P; Saleri N; Dembelé M; Ouedraogo M; Badoum G; Pinsi G; Migliori GB; Matteelli A; Cirillo DM
BMC Infect Dis; 2009 Aug; 9():142. PubMed ID: 19715569
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant TB prevalence study in 5 health institutions in Haiti.
Hoffmann J; Chedid C; Ocheretina O; Masetti C; Joseph P; Mabou MM; Mathon JE; Francois EM; Gebelin J; Babin FX; Raskine L; Pape JW
PLoS One; 2021; 16(3):e0248707. PubMed ID: 33735224
[TBL] [Abstract][Full Text] [Related]
10. Detection of multidrug-resistant tuberculosis using MGIT™(TM) and MAS-PCR in Tripura, India.
Majumdar T; Bhattacharya S; Barman D; Bhoumik P; Bir R
Int J Tuberc Lung Dis; 2016 Feb; 20(2):166-9. PubMed ID: 26792467
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of Mycobacterium tuberculosis strains circulating in Pskov region].
Viazovaia AA; Zhuravlev VIu; Mokrousov IV; Otten TF; Pavlova EP; Krishevich VV; Vishnevskiĭ BI; Narvskaia OV
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):27-31. PubMed ID: 22308723
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of Mycobacterium tuberculosis Complex Strains Isolated from the Samples of Patients Living in Northern Syria].
Gazel D; Çeylan K; Çalışkantürk G; Karslıgil T
Mikrobiyol Bul; 2023 Jul; 57(3):444-453. PubMed ID: 37462307
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.
Chen C; Kong W; Zhu L; Zhou Y; Peng H; Shao Y; Song H; Liu Q; Li G; Shi J; Zhong C; Zhu L; Ding X; Yu H; Yang H; Lu W
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1034-9. PubMed ID: 25189549
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment.
Abate D; Tedla Y; Meressa D; Ameni G
Int J Tuberc Lung Dis; 2014 Aug; 18(8):946-51. PubMed ID: 25199009
[TBL] [Abstract][Full Text] [Related]
16. Role of real-time PCR for detection of tuberculosis and drug resistance directly from clinical samples.
Rao P; Chawla K; Shenoy VP; Mukhopadhyay C
Indian J Tuberc; 2016 Jul; 63(3):149-153. PubMed ID: 27865235
[TBL] [Abstract][Full Text] [Related]
17. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
Farooqi JQ; Khan E; Alam SM; Ali A; Hasan Z; Hasan R
J Pak Med Assoc; 2012 Aug; 62(8):767-72. PubMed ID: 23862246
[TBL] [Abstract][Full Text] [Related]
18. Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
Sagar T; Singh NP; Kashyap B; Kaur IR
J Postgrad Med; 2013; 59(3):173-6. PubMed ID: 24029192
[TBL] [Abstract][Full Text] [Related]
19. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
Kumar P; Kumar P; Balooni V; Singh S
Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Mycobacterium Tuberculosis Positive Patients Screened for Drug-Resistant Tuberculosis at a Tertiary Health Facility in Lagos, Nigeria.
Kuyinu YA; Odugbemi BA; Salisu-Olatunji SO; Adepoju FO; Odusanya OO
J Natl Med Assoc; 2018 Feb; 110(1):88-91. PubMed ID: 29510850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
